Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127205101 | 12720510 | 1 | I | 20160901 | 20160907 | 20160907 | PER | US-GLAXOSMITHKLINE-US2016GSK128444 | GLAXOSMITHKLINE | 0.00 | M | Y | 0.00000 | 20160907 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127205101 | 12720510 | 1 | PS | ADVAIR DISKUS | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | UNK | U | 21077 | INHALATION POWDER | |||||||||
| 127205101 | 12720510 | 2 | SS | VENTOLIN HFA | ALBUTEROL SULFATE | 1 | UNK | U | 6ZP6560 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127205101 | 12720510 | 1 | Chronic obstructive pulmonary disease |
| 127205101 | 12720510 | 2 | Asthma |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127205101 | 12720510 | Lacrimation increased | |
| 127205101 | 12720510 | Multiple allergies | |
| 127205101 | 12720510 | Nasal congestion | |
| 127205101 | 12720510 | Nasopharyngitis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127205101 | 12720510 | 1 | 2013 | 0 | ||
| 127205101 | 12720510 | 2 | 2013 | 0 |